𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epinephrine: A new pharmacologic treatment for no-reflow?

✍ Scribed by Donald S. Baim


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
35 KB
Volume
57
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Adenosine for reversal of β€œno reflow”
✍ Tim A. Fischell; Malcolm T. Foster III πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 8 KB πŸ‘ 1 views
A pharmacologic strategy for the treatme
✍ Stephen L. Dewey; Jonathan D. Brodie; Madina Gerasimov; Bryan Horan; Eliot L. Ga πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

Like many psychostimulant drugs, nicotine elevates extracellular and synaptic dopamine (DA) concentrations in the nucleus accumbens (NAc). This elevation has been linked to its reinforcing properties. Dopaminergic transmission within the NAc is modulated by gamma-aminobutyric acid (GABA). Therefore,

Setting New Standards for the Pharmacolo
✍ R. KUMAR πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 161 KB πŸ‘ 2 views

Three drugs are currently licensed for the treatment of panic disorder: the benzodiazepine, alprazolam; the tricyclic antidepressant, clomipramine; and, most recently, the selective serotonin reuptake inhibitor, paroxetine. Alprazolam and clomipramine are eective in the treatment of panic disorder,